Xylem (NYSE: XYL) reported Q2 EPS of $0.43, in-line with the analyst estimate of $0.43. Revenue for the quarter came in at $920 million versus the consensus estimate of $924.98 million.

Xylem sees FY2015 EPS of $1.82-$1.87, versus the consensus of $1.86. Xylem sees FY2015 revenue of $3.7 million.

On an organic basis, Xylem now expects to generate revenue growth of approximately one to two percent.

For earnings history and earnings-related data on Xylem (XYL) click here.